TRAIL逆轉人卵巢癌COC1/DDP細胞對DDP耐藥性的研究_《華西醫學》

作者：

李春梅 , 彭芝蘭 , 尹如鐵

四川大學華西第二醫院婦產科，四川成都 610041;

關鍵詞：

卵巢腫瘤 TRAIL 順鉑藥物耐受性

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

目的:研究TRAIL對卵巢癌COC1/DDP細胞生長的影響，以及化療藥物DDP等對TRAIL受體（DR4、DR5）表達的影響，揭示TRAIL與COC1/DDP細胞順鉑耐藥性的關系。方法:用MTT法檢測不同濃度TRAIL蛋白和TRAIL與DDP聯合用藥對COC1/DDP細胞生長的影響，用RTPCR方法檢測DDP對TRAIL受體（DR4、DR5）表達的影響。結果:①TRAIL蛋白對COC1/DDP細胞生長有抑制作用，且隨著TRAIL蛋白濃度升高，細胞抑制率逐漸上升。②DDP（2.5μg/mL）對COC1/DDP細胞生長抑制作用較弱（抑制率為3.31%），DDP在加入TRAIL蛋白后對細胞生長抑制率顯著升高（P lt;0.05）。③DDP使COC1/DDP細胞的DR5表達水平顯著增強為正常對照組的3.54倍（P lt;0.001）。結論:TRAIL蛋白對COC1/DDP細胞生長有抑制作用，DDP與TRAIL聯合使用COC1/DDP細胞生長抑制更明顯，TRAIL可逆轉COC1/DDP細胞對DDP的耐藥性，耐藥性的逆轉可能與DDP導致TRAIL受體DR5水平增高促進了腫瘤細胞的凋亡有關。

引用本文： 李春梅,彭芝蘭,尹如鐵. TRAIL逆轉人卵巢癌COC1/DDP細胞對DDP耐藥性的研究. 華西醫學, 2009, 24(1): 105-107. doi: 復制

1.	Griffith TS，Chin WA，Jackson GC，et al. Intracellular regulation of TRAILinduced apoptosis in human melanoma cells[J].J Immunol，1998，161（6）:2833-2840..
2.	Wiley SR，Schooley K，Smolak PJ，et al.Indentification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity，1995，3（6）:673-682..
3.	Sheridan JP，Marsters SA，Pitti RM，et al.Control of TRAILinduced apoptosis by a family of signaling and decoy receptors[J].Science，1997，277（5327）:818-821..
4.	Sprick MR，Weigand MA，Rieser E，et al.FADD/MORT1 and caspase8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2[J].Immunity，2000，12（6）:599-609..
5.	Thomas LR，Henson A，Reed JC，et al.Direct binding of Fasassociated death domain （FADD） to the tumor necrosis factorrelated apoptosisinducing ligand receptor DR5 is regulated by the death effector domain of FADD[J].J Biol Chem，2004，279（31）:32780-32785..
6.	李春梅，彭芝蘭，尹如鐵.TRAIL蛋白對卵巢癌COC1和COC1/DDP細胞生長及促凋亡作用研究[J].四川腫瘤防治，2006，19（3）:161-166..
7.	Cuello M，Ettenberg SA，Nau MM，et al.Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells[J].Gynecol Oncol，2001，81（3）:380-390..
8.	Arts HJ，de Jong S，Hollema H，et al.Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma[J].Gynecol Oncol，2004，92（3）:794-800..
9.	Tomek S，Horak P，Pribill I，et al.Resistance to TRAILinduced apoptosis in ovarian cancer cell lines is overcome by cotreatment with cytotoxic drugs[J].Gynecol Oncol，2004，94（1）:107-114..

1. Griffith TS，Chin WA，Jackson GC，et al. Intracellular regulation of TRAILinduced apoptosis in human melanoma cells[J].J Immunol，1998，161（6）:2833-2840..
2. Wiley SR，Schooley K，Smolak PJ，et al.Indentification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity，1995，3（6）:673-682..
3. Sheridan JP，Marsters SA，Pitti RM，et al.Control of TRAILinduced apoptosis by a family of signaling and decoy receptors[J].Science，1997，277（5327）:818-821..
4. Sprick MR，Weigand MA，Rieser E，et al.FADD/MORT1 and caspase8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2[J].Immunity，2000，12（6）:599-609..
5. Thomas LR，Henson A，Reed JC，et al.Direct binding of Fasassociated death domain （FADD） to the tumor necrosis factorrelated apoptosisinducing ligand receptor DR5 is regulated by the death effector domain of FADD[J].J Biol Chem，2004，279（31）:32780-32785..
6. 李春梅，彭芝蘭，尹如鐵.TRAIL蛋白對卵巢癌COC1和COC1/DDP細胞生長及促凋亡作用研究[J].四川腫瘤防治，2006，19（3）:161-166..
7. Cuello M，Ettenberg SA，Nau MM，et al.Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells[J].Gynecol Oncol，2001，81（3）:380-390..
8. Arts HJ，de Jong S，Hollema H，et al.Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma[J].Gynecol Oncol，2004，92（3）:794-800..
9. Tomek S，Horak P，Pribill I，et al.Resistance to TRAILinduced apoptosis in ovarian cancer cell lines is overcome by cotreatment with cytotoxic drugs[J].Gynecol Oncol，2004，94（1）:107-114..

《華西醫學》

TRAIL逆轉人卵巢癌COC1/DDP細胞對DDP耐藥性的研究

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《華西醫學》

TRAIL逆轉人卵巢癌COC1/DDP細胞對DDP耐藥性的研究

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料